MEDIA COVERAGE - OSIVAX

MEDIA COVERAGE

Osivax secures $36M in grant, equity funding for flu, coronavirus vaccine programs
Published on July 8, 2020

French biotech gets funding for universal flu and coronavirus vaccines
Published on July 9, 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines
Published on July 8, 2020

French biotech Osivax nabs funding boost for universal flu, coronavirus vaccine work
Published on July 8, 2020

Scrip Informa Phama Intelligence - Osivax CEO Hopes Vaccines Maker Can Develop Universal Flu 'Silver Bullet'
Published on August 14, 2019

European Biotechnology - €8M for universal flu vaccine
Published on July 11, 2019

RTBF - Une société biotech française séduite par Liège
Published on July 11, 2019

BioWorld - Osivax advancing Universal flu vaccine with $9M series A
Published on July 11, 2019

FierceBiotech - Osivax raises €8M for universal flu vaccine clinical trials
Published on July 10, 2019

LABIOTECH.eu - French Startup's Universal Flu Vaccine Development Boosted by €8M Series A
Published on July 10, 2019

EU-Startups - Lyon-based biotech startup Osivax raises €8 million in financing to develop novel, universal flu vaccines
Published on July 10, 2019

FinSMEs - Osivax Raises €8M in Series A Funding
Published on July 10, 2019

L'echo - Osivax s'installe à Liège pour y développer un vaccin universel contre la grippe
Published on July 10, 2019

Ccimag - Osivax lève 8 millions d’euros et planifie l’ouverture de bureaux à Liège
Published on July 10, 2019

Siliconcanals - French biotech startup Osivax secures €8M to develop universal vaccine against influenza
Published on July 10, 2019

LABIOTECH.eu - The Top 10 Biotechs You’ll Find in Lyon
Published on July 10, 2019

LeProgres - Le vaccin contre la grippe d’Osivax pourrait générer plus d’un milliard par an
Published on April 24, 2018

LABIOTECH.eu - This Newly Founded French Biotech is All About Vaccines
Published on June 23, 2017